- Home
- TCBS vs MAIA Comparison
TCBS vs MAIA Comparison
Compare TCBS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- MAIA
- Stock Information
- Founded
- TCBS 1934
- MAIA 2018
- Country
- TCBS United States
- MAIA United States
- Employees
- TCBS N/A
- MAIA N/A
- Industry
- TCBS Banks
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- TCBS Finance
- MAIA Health Care
- Exchange
- TCBS Nasdaq
- MAIA Nasdaq
- Market Cap
- TCBS 46.9M
- MAIA 52.7M
- IPO Year
- TCBS N/A
- MAIA 2022
- Fundamental
- Price
- TCBS $15.16
- MAIA $2.08
- Analyst Decision
- TCBS
- MAIA
- Analyst Count
- TCBS 0
- MAIA 0
- Target Price
- TCBS N/A
- MAIA N/A
- AVG Volume (30 Days)
- TCBS 4.7K
- MAIA 175.0K
- Earning Date
- TCBS 11-13-2024
- MAIA 11-12-2024
- Dividend Yield
- TCBS 1.07%
- MAIA N/A
- EPS Growth
- TCBS N/A
- MAIA N/A
- EPS
- TCBS N/A
- MAIA N/A
- Revenue
- TCBS $9,858,000.00
- MAIA N/A
- Revenue This Year
- TCBS N/A
- MAIA N/A
- Revenue Next Year
- TCBS N/A
- MAIA N/A
- P/E Ratio
- TCBS N/A
- MAIA N/A
- Revenue Growth
- TCBS N/A
- MAIA N/A
- 52 Week Low
- TCBS $12.61
- MAIA $0.95
- 52 Week High
- TCBS $15.24
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- TCBS 73.88
- MAIA 45.13
- Support Level
- TCBS $14.90
- MAIA $1.93
- Resistance Level
- TCBS $15.18
- MAIA $2.63
- Average True Range (ATR)
- TCBS 0.08
- MAIA 0.20
- MACD
- TCBS 0.02
- MAIA 0.03
- Stochastic Oscillator
- TCBS 100.00
- MAIA 37.37
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.